July 2025 FDA Recall Drug by Central Admixture Pharmacy Services, Inc (caps) Los Angeles (D-0530-2025 - Lack of Processing Controls; prescriptions were compounded in an ISO-5 area where it was identified that a daily cleaning step was not sufficiently documented.)

This Class II drug recall was voluntarily initiated by Central Admixture Pharmacy Services, Inc (caps) Los Angeles on July 1, 2025 for the product Drug. The FDA reported the reason for recall as lack of processing controls; prescriptions were compounded in an iso-5 area where it was identified that a daily cleaning step was not sufficiently documented.. The product was distributed in CA and the recall is currently ongoing.

Recall Number: D-0530-2025

Reason for Recall
Lack of Processing Controls; prescriptions were compounded in an ISO-5 area where it was identified that a daily cleaning step was not sufficiently documented.
Initiated
07-01-2025
Reported
07-23-2025
Quantity
2 bags

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles
PERIPHERAL PARENTERAL NUTRITION, Compounded Sterile Preparation, Refrigerated Injection, Rx Only, Single Dose Injection, a) 1440 mL bag, b) 1700 mL bag, Central Admixture Pharmacy Services, Inc, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90870.

Batch or Lot Expiration Information

Lot# Lot: a) 11-4785290-0-1, BUD: 6/19/2025 @ 11:32 pm; b) 11-4785217-0-1, BUD: 6/19/2025 @ 10:25 pm.